+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Clinical Trial Management Systems (CTMS) - Global Market Trajectory & Analytics

  • ID: 1824112
  • Report
  • July 2020
  • Region: Global
  • 245 Pages
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • ArisGlobal, LLC (USA)
  • BioClinica, Inc. (USA)
  • Bio-Optronics, Inc. (USA)
  • DSG, Inc. (USA)
  • IBM Watson Health (USA)
  • Medidata Solutions (USA)
  • MORE
Global Clinical Trial Management Systems (CTMS) Market to Reach $1.6 Billion by 2027

Amid the COVID-19 crisis, the global market for Clinical Trial Management Systems (CTMS) estimated at US$728.8 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at aCAGR of 11.9% over the period 2020-2027. Enterprise CTMS, one of the segments analyzed in the report, is projected to record 12.8% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Site CTMS segment is readjusted to a revised 9.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $215.1 Million, While China is Forecast to Grow at 11.4% CAGR

The Clinical Trial Management Systems (CTMS) market in the U.S. is estimated at US$215.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$279.7 Million by the year 2027 trailing a CAGR of 11.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.6% and 10% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.6% CAGR.We bring years of research experience to this 15th edition of our report. The 245-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:
  • ArisGlobal LLC
  • BioClinica Inc.
  • Bio-Optronics Inc.
  • DSG Inc.
  • eResearch Technology Inc.
  • IBM Watson Health
  • Medidata Solutions
  • MedNet Solutions
  • Nextrials Inc.
  • Oracle Corp.
  • PAREXEL International Corp.
  • Trial By Fire Solutions LLC
  • Veeva Systems Inc.

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ArisGlobal, LLC (USA)
  • BioClinica, Inc. (USA)
  • Bio-Optronics, Inc. (USA)
  • DSG, Inc. (USA)
  • IBM Watson Health (USA)
  • Medidata Solutions (USA)
  • MORE

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Clinical Trial Management Systems (CTMS) Gain Ground

Recent Market Activity

Benefits Offered by CTMS

Global Market Overview

Clinical Trial Management Systems Market to Post Explosive Growth

Web-based Systems Dominate, Cloud-Based to Witness Fastest Growth

Key Players in the CTMS Market

Developed Countries Rule the Market

Pharmaceutical Firms and CROs to Drive Adoption Rate

Noteworthy Transformations in the Global Clinical Trial Sector

Global Competitor Market Shares

Clinical Trial Management Systems (CTMS) Competitor Market Share Scenario Worldwide (in %): 2018 & 2029

Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

ArisGlobal, LLC (USA)

BioClinica, Inc. (USA)

Bio-Optronics, Inc. (USA)

DSG, Inc. (USA)

eResearch Technology, Inc. (USA)

IBM Watson Health (USA)

MedNet Solutions (USA)

Medidata Solutions (USA)

Nextrials, Inc. (USA)

Oracle Corp. (USA)

PAREXEL International Corp. (USA)

Trial By Fire Solutions, LLC (USA)

Veeva Systems, Inc. (USA)

Winchester Business Systems (USA)

3. MARKET TRENDS & DRIVERS

Surging Global Population Offers Increased Growth Opportunities

Increased Spend on R&D - An Important Growth Driver

CROs - The Targeted Customers for CTMS

Outsourcing of R&D Projects to Propel CRO Market, Drives CTMS Demand

CROs Adept with New Technologies to See More Business in Future

Rise in Clinical Trial Complexities Propels CTMS Demand

Pharmaceutical & Biopharmaceutical Trends to Support CTMS Demand

Adoption of Digital Technologies Gains Pace

Clinical Trial Operators Demand Efficient Data Management Platforms

DLB System’s Solution with Data Management Tools

Systems Integration Becomes Imperative

Technological Innovations Drive Market Growth

MC10 Introduces BioStampRC System to Capture Clinical Trial Data

UF Health Cancer Center Unveils OnCore® Clinical Trials Management System

UAB Unveils Innovative Technology to Streamline Clinical Trial Management Solution

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Clinical Trial Management Systems (CTMS) Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
TABLE 2: Clinical Trial Management Systems (CTMS) Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2012-2019
TABLE 3: Clinical Trial Management Systems (CTMS) Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027
TABLE 4: Enterprise CTMS (Type) World Market by Region/Country in US$ Thousand: 2020 to 2027
TABLE 5: Enterprise CTMS (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019
TABLE 6: Enterprise CTMS (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 7: Site CTMS (Type) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
TABLE 8: Site CTMS (Type) Historic Market Perspective by Region/Country in US$ Thousand: 2012 to 2019
TABLE 9: Site CTMS (Type) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027
TABLE 10: Web-based (Hosted) (Delivery Mode) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027
TABLE 11: Web-based (Hosted) (Delivery Mode) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2012 to 2019
TABLE 12: Web-based (Hosted) (Delivery Mode) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 13: Licensed Enterprise (On-Premise) (Delivery Mode) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027
TABLE 14: Licensed Enterprise (On-Premise) (Delivery Mode) Market Historic Review by Region/Country in US$ Thousand: 2012 to 2019
TABLE 15: Licensed Enterprise (On-Premise) (Delivery Mode) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027
TABLE 16: Cloud-based (SaaS) (Delivery Mode) World Market by Region/Country in US$ Thousand: 2020 to 2027
TABLE 17: Cloud-based (SaaS) (Delivery Mode) Historic Market Analysis by Region/Country in US$ Thousand: 2012 to 2019
TABLE 18: Cloud-based (SaaS) (Delivery Mode) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027
TABLE 19: Pharmaceutical & Biopharmaceutical (End-Use) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through 2027
TABLE 20: Pharmaceutical & Biopharmaceutical (End-Use) Analysis of Historic Sales in US$ Thousand by Region/Country for the Years 2012 to 2019
TABLE 21: Pharmaceutical & Biopharmaceutical (End-Use) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027
TABLE 22: Contract Research Organizations (End-Use) Global Opportunity Assessment in US$ Thousand by Region/Country: 2020-2027
TABLE 23: Contract Research Organizations (End-Use) Historic Sales Analysis in US$ Thousand by Region/Country: 2012-2019
TABLE 24: Contract Research Organizations (End-Use) Percentage Share Breakdown of Global Sales by Region/Country: 2012 VS 2020 VS 2027
TABLE 25: Medical Devices (End-Use) Worldwide Sales in US$ Thousand by Region/Country: 2020-2027
TABLE 26: Medical Devices (End-Use) Historic Demand Patterns in US$ Thousand by Region/Country: 2012-2019
TABLE 27: Medical Devices (End-Use) Market Share Shift across Key Geographies: 2012 VS 2020 VS 2027
TABLE 28: Other End-Uses (End-Use) Global Market Estimates & Forecasts in US$ Thousand by Region/Country: 2020-2027
TABLE 29: Other End-Uses (End-Use) Retrospective Demand Analysis in US$ Thousand by Region/Country: 2012-2019
TABLE 30: Other End-Uses (End-Use) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Clinical Trial Management Systems (CTMS) Market Share (in %) by Company: 2018 & 2025

Market Analytics
TABLE 31: United States Clinical Trial Management Systems (CTMS) Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027
TABLE 32: Clinical Trial Management Systems (CTMS) Market in the United States by Type: A Historic Review in US$ Thousand for 2012-2019
TABLE 33: United States Clinical Trial Management Systems (CTMS) Market Share Breakdown by Type: 2012 VS 2020 VS 2027
TABLE 34: United States Clinical Trial Management Systems (CTMS) Market Estimates and Projections in US$ Thousand by Delivery Mode: 2020 to 2027
TABLE 35: Clinical Trial Management Systems (CTMS) Market in the United States by Delivery Mode: A Historic Review in US$ Thousand for 2012-2019
TABLE 36: United States Clinical Trial Management Systems (CTMS) Market Share Breakdown by Delivery Mode: 2012 VS 2020 VS 2027
TABLE 37: United States Clinical Trial Management Systems (CTMS) Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027
TABLE 38: Clinical Trial Management Systems (CTMS) Historic Demand Patterns in the United States by End-Use in US$ Thousand for 2012-2019
TABLE 39: Clinical Trial Management Systems (CTMS) Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027

CANADA

TABLE 40: Canadian Clinical Trial Management Systems (CTMS) Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027
TABLE 41: Canadian Clinical Trial Management Systems (CTMS) Historic Market Review by Type in US$ Thousand: 2012-2019
TABLE 42: Clinical Trial Management Systems (CTMS) Market in Canada: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027
TABLE 43: Canadian Clinical Trial Management Systems (CTMS) Market Estimates and Forecasts in US$ Thousand by Delivery Mode: 2020 to 2027
TABLE 44: Canadian Clinical Trial Management Systems (CTMS) Historic Market Review by Delivery Mode in US$ Thousand: 2012-2019
TABLE 45: Clinical Trial Management Systems (CTMS) Market in Canada: Percentage Share Breakdown of Sales by Delivery Mode for 2012, 2020, and 2027
TABLE 46: Canadian Clinical Trial Management Systems (CTMS) Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
TABLE 47: Clinical Trial Management Systems (CTMS) Market in Canada: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019
TABLE 48: Canadian Clinical Trial Management Systems (CTMS) Market Share Analysis by End-Use: 2012 VS 2020 VS 2027

JAPAN

TABLE 49: Japanese Market for Clinical Trial Management Systems (CTMS): Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027
TABLE 50: Clinical Trial Management Systems (CTMS) Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019
TABLE 51: Japanese Clinical Trial Management Systems (CTMS) Market Share Analysis by Type: 2012 VS 2020 VS 2027
TABLE 52: Japanese Market for Clinical Trial Management Systems (CTMS): Annual Sales Estimates and Projections in US$ Thousand by Delivery Mode for the Period 2020-2027
TABLE 53: Clinical Trial Management Systems (CTMS) Market in Japan: Historic Sales Analysis in US$ Thousand by Delivery Mode for the Period 2012-2019
TABLE 54: Japanese Clinical Trial Management Systems (CTMS) Market Share Analysis by Delivery Mode: 2012 VS 2020 VS 2027
TABLE 55: Japanese Demand Estimates and Forecasts for Clinical Trial Management Systems (CTMS) in US$ Thousand by End-Use: 2020 to 2027
TABLE 56: Japanese Clinical Trial Management Systems (CTMS) Market in US$ Thousand by End-Use: 2012-2019
TABLE 57: Clinical Trial Management Systems (CTMS) Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027

CHINA

TABLE 58: Chinese Clinical Trial Management Systems (CTMS) Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027
TABLE 59: Clinical Trial Management Systems (CTMS) Historic Market Analysis in China in US$ Thousand by Type: 2012-2019
TABLE 60: Chinese Clinical Trial Management Systems (CTMS) Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 61: Chinese Clinical Trial Management Systems (CTMS) Market Growth Prospects in US$ Thousand by Delivery Mode for the Period 2020-2027
TABLE 62: Clinical Trial Management Systems (CTMS) Historic Market Analysis in China in US$ Thousand by Delivery Mode: 2012-2019
TABLE 63: Chinese Clinical Trial Management Systems (CTMS) Market by Delivery Mode: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 64: Chinese Demand for Clinical Trial Management Systems (CTMS) in US$ Thousand by End-Use: 2020 to 2027
TABLE 65: Clinical Trial Management Systems (CTMS) Market Review in China in US$ Thousand by End-Use: 2012-2019
TABLE 66: Chinese Clinical Trial Management Systems (CTMS) Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027

EUROPE

Market Facts & Figures

European Clinical Trial Management Systems (CTMS) Market: Competitor Market Share Scenario (in %) for 2018 & 2025

Market Analytics
TABLE 67: European Clinical Trial Management Systems (CTMS) Market Demand Scenario in US$ Thousand by Region/Country: 2020-2027
TABLE 68: Clinical Trial Management Systems (CTMS) Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2012-2019
TABLE 69: European Clinical Trial Management Systems (CTMS) Market Share Shift by Region/Country: 2012 VS 2020 VS 2027
TABLE 70: European Clinical Trial Management Systems (CTMS) Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027
TABLE 71: Clinical Trial Management Systems (CTMS) Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2012-2019
TABLE 72: European Clinical Trial Management Systems (CTMS) Market Share Breakdown by Type: 2012 VS 2020 VS 2027
TABLE 73: European Clinical Trial Management Systems (CTMS) Market Estimates and Forecasts in US$ Thousand by Delivery Mode: 2020-2027
TABLE 74: Clinical Trial Management Systems (CTMS) Market in Europe in US$ Thousand by Delivery Mode: A Historic Review for the Period 2012-2019
TABLE 75: European Clinical Trial Management Systems (CTMS) Market Share Breakdown by Delivery Mode: 2012 VS 2020 VS 2027
TABLE 76: European Clinical Trial Management Systems (CTMS) Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
TABLE 77: Clinical Trial Management Systems (CTMS) Market in Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019
TABLE 78: European Clinical Trial Management Systems (CTMS) Market Share Analysis by End-Use: 2012 VS 2020 VS 2027

FRANCE

TABLE 79: Clinical Trial Management Systems (CTMS) Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
TABLE 80: French Clinical Trial Management Systems (CTMS) Historic Market Scenario in US$ Thousand by Type: 2012-2019
TABLE 81: French Clinical Trial Management Systems (CTMS) Market Share Analysis by Type: 2012 VS 2020 VS 2027
TABLE 82: Clinical Trial Management Systems (CTMS) Market in France by Delivery Mode: Estimates and Projections in US$ Thousand for the Period 2020-2027
TABLE 83: French Clinical Trial Management Systems (CTMS) Historic Market Scenario in US$ Thousand by Delivery Mode: 2012-2019
TABLE 84: French Clinical Trial Management Systems (CTMS) Market Share Analysis by Delivery Mode: 2012 VS 2020 VS 2027
TABLE 85: Clinical Trial Management Systems (CTMS) Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027
TABLE 86: French Clinical Trial Management Systems (CTMS) Historic Market Review in US$ Thousand by End-Use: 2012-2019
TABLE 87: French Clinical Trial Management Systems (CTMS) Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027

GERMANY

TABLE 88: Clinical Trial Management Systems (CTMS) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027
TABLE 89: German Clinical Trial Management Systems (CTMS) Historic Market Analysis in US$ Thousand by Type: 2012-2019
TABLE 90: German Clinical Trial Management Systems (CTMS) Market Share Breakdown by Type: 2012 VS 2020 VS 2027
TABLE 91: Clinical Trial Management Systems (CTMS) Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Delivery Mode for the Period 2020-2027
TABLE 92: German Clinical Trial Management Systems (CTMS) Historic Market Analysis in US$ Thousand by Delivery Mode: 2012-2019
TABLE 93: German Clinical Trial Management Systems (CTMS) Market Share Breakdown by Delivery Mode: 2012 VS 2020 VS 2027
TABLE 94: Clinical Trial Management Systems (CTMS) Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027
TABLE 95: German Clinical Trial Management Systems (CTMS) Market in Retrospect in US$ Thousand by End-Use: 2012-2019
TABLE 96: Clinical Trial Management Systems (CTMS) Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027

ITALY

TABLE 97: Italian Clinical Trial Management Systems (CTMS) Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027
TABLE 98: Clinical Trial Management Systems (CTMS) Historic Market Analysis in Italy in US$ Thousand by Type: 2012-2019
TABLE 99: Italian Clinical Trial Management Systems (CTMS) Market by Type: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 100: Italian Clinical Trial Management Systems (CTMS) Market Growth Prospects in US$ Thousand by Delivery Mode for the Period 2020-2027
TABLE 101: Clinical Trial Management Systems (CTMS) Historic Market Analysis in Italy in US$ Thousand by Delivery Mode: 2012-2019
TABLE 102: Italian Clinical Trial Management Systems (CTMS) Market by Delivery Mode: Percentage Breakdown of Sales for 2012, 2020, and 2027
TABLE 103: Italian Demand for Clinical Trial Management Systems (CTMS) in US$ Thousand by End-Use: 2020 to 2027
TABLE 104: Clinical Trial Management Systems (CTMS) Market Review in Italy in US$ Thousand by End-Use: 2012-2019
TABLE 105: Italian Clinical Trial Management Systems (CTMS) Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027

UNITED KINGDOM

TABLE 106: United Kingdom Market for Clinical Trial Management Systems (CTMS): Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027
TABLE 107: Clinical Trial Management Systems (CTMS) Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2012-2019
TABLE 108: United Kingdom Clinical Trial Management Systems (CTMS) Market Share Analysis by Type: 2012 VS 2020 VS 2027
TABLE 109: United Kingdom Market for Clinical Trial Management Systems (CTMS): Annual Sales Estimates and Projections in US$ Thousand by Delivery Mode for the Period 2020-2027
TABLE 110: Clinical Trial Management Systems (CTMS) Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Delivery Mode for the Period 2012-2019
TABLE 111: United Kingdom Clinical Trial Management Systems (CTMS) Market Share Analysis by Delivery Mode: 2012 VS 2020 VS 2027
TABLE 112: United Kingdom Demand Estimates and Forecasts for Clinical Trial Management Systems (CTMS) in US$ Thousand by End-Use: 2020 to 2027
TABLE 113: United Kingdom Clinical Trial Management Systems (CTMS) Market in US$ Thousand by End-Use: 2012-2019
TABLE 114: Clinical Trial Management Systems (CTMS) Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027

REST OF EUROPE

TABLE 115: Rest of Europe Clinical Trial Management Systems (CTMS) Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027
TABLE 116: Clinical Trial Management Systems (CTMS) Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2012-2019
TABLE 117: Rest of Europe Clinical Trial Management Systems (CTMS) Market Share Breakdown by Type: 2012 VS 2020 VS 2027
TABLE 118: Rest of Europe Clinical Trial Management Systems (CTMS) Market Estimates and Forecasts in US$ Thousand by Delivery Mode: 2020-2027
TABLE 119: Clinical Trial Management Systems (CTMS) Market in Rest of Europe in US$ Thousand by Delivery Mode: A Historic Review for the Period 2012-2019
TABLE 120: Rest of Europe Clinical Trial Management Systems (CTMS) Market Share Breakdown by Delivery Mode: 2012 VS 2020 VS 2027
TABLE 121: Rest of Europe Clinical Trial Management Systems (CTMS) Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
TABLE 122: Clinical Trial Management Systems (CTMS) Market in Rest of Europe: Summarization of Historic Demand in US$ Thousand by End-Use for the Period 2012-2019
TABLE 123: Rest of Europe Clinical Trial Management Systems (CTMS) Market Share Analysis by End-Use: 2012 VS 2020 VS 2027

ASIA-PACIFIC

TABLE 124: Clinical Trial Management Systems (CTMS) Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
TABLE 125: Asia-Pacific Clinical Trial Management Systems (CTMS) Historic Market Scenario in US$ Thousand by Type: 2012-2019
TABLE 126: Asia-Pacific Clinical Trial Management Systems (CTMS) Market Share Analysis by Type: 2012 VS 2020 VS 2027
TABLE 127: Clinical Trial Management Systems (CTMS) Market in Asia-Pacific by Delivery Mode: Estimates and Projections in US$ Thousand for the Period 2020-2027
TABLE 128: Asia-Pacific Clinical Trial Management Systems (CTMS) Historic Market Scenario in US$ Thousand by Delivery Mode: 2012-2019
TABLE 129: Asia-Pacific Clinical Trial Management Systems (CTMS) Market Share Analysis by Delivery Mode: 2012 VS 2020 VS 2027
TABLE 130: Clinical Trial Management Systems (CTMS) Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027
TABLE 131: Asia-Pacific Clinical Trial Management Systems (CTMS) Historic Market Review in US$ Thousand by End-Use: 2012-2019
TABLE 132: Asia-Pacific Clinical Trial Management Systems (CTMS) Market Share Analysis: A 17-Year Perspectiveby End-Use for 2012, 2020, and 2027

REST OF WORLD

TABLE 133: Rest of World Clinical Trial Management Systems (CTMS) Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027
TABLE 134: Rest of World Clinical Trial Management Systems (CTMS) Historic Market Review by Type in US$ Thousand: 2012-2019
TABLE 135: Clinical Trial Management Systems (CTMS) Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2012, 2020, and 2027
TABLE 136: Rest of World Clinical Trial Management Systems (CTMS) Market Estimates and Forecasts in US$ Thousand by Delivery Mode: 2020 to 2027
TABLE 137: Rest of World Clinical Trial Management Systems (CTMS) Historic Market Review by Delivery Mode in US$ Thousand: 2012-2019
TABLE 138: Clinical Trial Management Systems (CTMS) Market in Rest of World: Percentage Share Breakdown of Sales by Delivery Mode for 2012, 2020, and 2027
TABLE 139: Rest of World Clinical Trial Management Systems (CTMS) Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
TABLE 140: Clinical Trial Management Systems (CTMS) Market in Rest of World: Summarization of Historic Demand Patterns in US$ Thousand by End-Use for 2012-2019
TABLE 141: Rest of World Clinical Trial Management Systems (CTMS) Market Share Analysis by End-Use: 2012 VS 2020 VS 2027

IV. COMPETITION

Total Companies Profiled: 62

Note: Product cover images may vary from those shown
  • ArisGlobal, LLC (USA)
  • BioClinica, Inc. (USA)
  • Bio-Optronics, Inc. (USA)
  • DSG, Inc. (USA)
  • eResearch Technology, Inc. (USA)
  • IBM Watson Health (USA)
  • MedNet Solutions (USA)
  • Medidata Solutions (USA)
  • Nextrials, Inc. (USA)
  • Oracle Corp. (USA)
  • PAREXEL International Corp. (USA)
  • Trial By Fire Solutions, LLC (USA)
  • Veeva Systems, Inc. (USA)
  • Winchester Business Systems (USA)
Note: Product cover images may vary from those shown
Adroll
adroll